PUS1 is a novel biomarker for predicting poor outcomes and triple-negative status in breast cancer
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
PUS1 is a novel biomarker for predicting poor outcomes and triple-negative status in breast cancer
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2022-11-15
DOI
10.3389/fonc.2022.1030571
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pseudouridine synthases modify human pre-mRNA co-transcriptionally and affect pre-mRNA processing
- (2022) Nicole M. Martinez et al. MOLECULAR CELL
- Non-canonical roles of canonical telomere binding proteins in cancers
- (2021) Semih Can Akincilar et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- HSP90-dependent PUS7 overexpression facilitates the metastasis of colorectal cancer cells by regulating LASP1 abundance
- (2021) Dan Song et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Modifications in an Emergency: The Role of N1-Methylpseudouridine in COVID-19 Vaccines
- (2021) Kellie D. Nance et al. ACS Central Science
- Cancer statistics, 2020
- (2020) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Mapping the epigenetic modifications of DNA and RNA
- (2020) Lin-Yong Zhao et al. Protein & Cell
- The nucleolar-related protein Dyskerin pseudouridine synthase 1 (DKC1) predicts poor prognosis in breast cancer
- (2020) Khloud A. Elsharawy et al. BRITISH JOURNAL OF CANCER
- The tRNA pseudouridine synthase TruB1 regulates the maturation of let‐7 miRNA
- (2020) Ryota Kurimoto et al. EMBO JOURNAL
- MAPK1/3 kinase-dependent ULK1 degradation attenuates mitophagy and promotes breast cancer bone metastasis
- (2020) Rong Deng et al. Autophagy
- PI3K/AKT/mTOR Signaling Pathway in Breast Cancer: From Molecular Landscape to Clinical Aspects
- (2020) Daniela Miricescu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
- Increased DKC1 expression in glioma and its significance in tumor cell proliferation, migration and invasion
- (2019) Fa-an Miao et al. INVESTIGATIONAL NEW DRUGS
- Where, When, and How: Context-Dependent Functions of RNA Methylation Writers, Readers, and Erasers
- (2019) Hailing Shi et al. MOLECULAR CELL
- DKC1 is a transcriptional target of GATA1 and drives upregulation of telomerase activity in normal human erythroblasts
- (2019) Laura A Richards et al. HAEMATOLOGICA
- mRNA structure determines modification by pseudouridine synthase 1
- (2019) Thomas M. Carlile et al. Nature Chemical Biology
- Natural products targeting the PI3K-Akt-mTOR signaling pathway in cancer: A novel therapeutic strategy
- (2019) Devesh Tewari et al. SEMINARS IN CANCER BIOLOGY
- PI3K Inhibitors in Breast Cancer Therapy
- (2019) Haley Ellis et al. Current Oncology Reports
- Pseudouridylation of tRNA-Derived Fragments Steers Translational Control in Stem Cells
- (2018) Nicola Guzzi et al. CELL
- UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses
- (2017) Darshan S. Chandrashekar et al. NEOPLASIA
- A novel autophagy/mitophagy inhibitor liensinine sensitizes breast cancer cells to chemotherapy through DNM1L-mediated mitochondrial fission
- (2015) Jing Zhou et al. Autophagy
- Pseudouridine profiling reveals regulated mRNA pseudouridylation in yeast and human cells
- (2014) Thomas M. Carlile et al. NATURE
- DKC1 overexpression associated with prostate cancer progression
- (2009) P Sieron et al. BRITISH JOURNAL OF CANCER
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search